SERPINE1 and hepatocellular carcinoma: As exemplified for plasminogen activator inhibitor-1 (PAI-1), we show that overexpression of this factor in human hepatocellular carcinoma (HCC) patients correlates with poor clinical outcome and expression of known YAP target genes.